text.skipToContent text.skipToNavigation
Need help? Please contact us

Lonza Bioscience Blog

Lonza's crew: From the lab to the track

It was a wet and wild September 25th around the RheinEnergieSTADION, but the dreary weather couldn’t dampen the spirits of nearly 20,000 participants who took part in North Rhine-Westphalia’s largest corporate race, the B2Run Cologne, Germany. 


This year, Lonza upped the ante with a whopping 39 participants, 15 more than last year. Clearly, word had spread that this event was not only about getting a workout, but also about doing good—without the risk of spreadsheets or PowerPoints. The B2Run isn’t just about racing against time; it’s a race for health, charity, and sustainability. And Lonza’s team showed up ready to crush all three.


Lonza, along with all 599 other companies at the B2Run, had the opportunity to register participants as "charity starters" for an additional €5 per person. This money went straight to DKMS, a German nonprofit organization fighting against blood cancer. For Lonza employees, the extra €5 wasn’t even a question—it was a no-brainer. After all, how often do you get to burn calories and fight cancer at the same time?

And it didn’t stop there. DKMS even set up a booth at the event where participants could register as stem cell donors, giving them the chance to save lives just by swabbing their cheek. Imagine finishing a 5 kilometer run, grabbing a celebratory banana, and then registering to be a superhero. That’s exactly what was happening at the B2Run. We’re not saying the free snacks were the real motivator here, but hey, a little post-run fuel never hurts, right? Or was it the free Lonza shirt?


 

If there’s one thing Lonza knows, it’s that teamwork makes everything better, whether it’s in the office, in the lab, or on the running track. Running together isn’t just about reaching the finish line first—it’s about motivating each other, sharing in the collective exhaustion, and having a laugh when someone (inevitably) takes a wrong turn because they were too busy chatting.


Written by

 

Peter
Director Scientific Support &  Service

CAR therapy for newbies:
Traps and pitfalls

The new trend of 'personalized medicine' requires careful preparation to achieve desired outcomes.


Mycoplasma contamination impairs transfection efficiency

Learn how mycoplasma affects your transfection and how you can obtain reliability, reproducibility, and consistency results.

Unlocking new possibilities with cryopreserved PBMCs

Insights in how cryopreservation impacts the viability and functionality of PBMCs.

Speeding up the PyroCell® MAT Testing

PyroCell® Monocyte Activation Test Rapid kits are reducing the total assay time to as little as 2 hours.

CRISPR screen of SAECs with 384-well Nucleofector® System

Find out more about the detailed automated arrayed CRISPR screening workflow for SAECs.

Lonza joins the B2Run in Cologne: Running for a cause

In a world where corporate culture is evolving, Lonza's engagement in events like the B2Run showcases their dedication to a healthier, more connected, and greener future.

Review on the CRISPR virtual event 2022

Read our short summary of the two sessions and a roundtable with interesting insights from our CRISPR experts.

Summary of strengths

Learn more about CAR-NK cells and automated production for immunotherapy.

How to create your own quote on our website

Find out how to generate and download a quote yourself on our Lonza Bioscience website.

CRISPR off-target effects

How to quickly detect off-targets when performing experiments with CRISPR/Cas9 technology.

Senescent zombie in primary cell culture

These zombie cells are known to reduce proliferation capacity and gradually decay culture.

The basics of clinical trials

Learn more about the clinical trials: What are they exactly? What types of trials are there? How many phases are there? What happens in each phase?

Endotoxin detection certificates of analysis

A General Guide

Why we are here

Read a story our Sales Team shared recently that touched our hearts and shows why we love our jobs at Lonza Bioscience.

Ph. Eur. announces end for Rabbit Pyrogen Test

R.I.P, RPT. Hello, MAT! 

New cellular models to study Parkinson disease

Genome-editing with 4D-Nucleofector® System was recently used to generate new cellular models for Parkinson’s disease. 

CRISPR in the classroom

Learn about genome editing in school. Dr. Martie Verschuren’s article is about teaching novel technologies for genome editing and how to keep students up to date in this exiting field of technology.

Allergy injections and endotoxins

Learn more about a real-life endotoxin test case

Testing unique samples for endotoxin. Where to begin?

A New Sample Testing Guide

Which cells should I use to research COVID-19?

Get information about factors to consider when selecting cells to study COVID-19 transmission.

Reprogramming of human PBMC into iPSC as a common method for disease research

PBMC collected from patients were reprogrammed into iPSC by Nucleofection. Generated IPSCs still carry the mutation causing the disease.

Endotoxin testing for cell and gene therapy products

Cell and gene therapy are a hot topic, but are you aware of the requirements around endotoxin testing for these products? Here is a short overview. 

How about using human primary hepatocytes in your experiments even if you need to transfect the cells?

A recent published application note is showing the transfection results of cryopreserved human hepatocytes with different substrates and keeping also an eye on functionality e.g. CYP enzymes.

Are you curious to know some details?

Comparing endotoxin testing results of modern recombinant to traditional LAL methods

Learn about Jay Bolden and co-workers extensive study of peer-reviewed literature to find publications where naturally contaminated samples were tested side by side  (same samples, only difference being the test method, i.e. rFC vs LAL/TAL).

Accurate cell counting using a Hemocytometer

For many experiments it is important to determine and know how many cells you have. Using a hemocytometer is rather basic and works well when done correctly. 

Lonza and Sanquin partner for commercialization of MAT

Lonza is bridging the gap from rabbit pyrogen testing to in vitro detection of pyrogens and provides another sustainable method for endotoxin and pyrogen detection to the market. 

Overcoming challenges in cryopreservation

This article summarizes the process of cryopreservation and includes tips and tricks to improve freezing methods. 

Setting up a primary cell or endotoxin product reserve

This blog post briefly describes the process that customers will follow to set up a product reserve.

Rapid screening of potential COVID-19 treatments using AI software

Identifying potential treatments for COVID-19 is of utmost importance right now. This blog post highlights some recent work done for high throughput screening of drug candidates for SARS-CoV-2 using software designed for phenotypic analysis. 

EP publishes chapter 2.6.32 introducing rFC

With the publication of supplement 10.3, EP officially introduces recombinant Factor C as a compendial method.

Using mesenchymal stem cells for therapeutic

The follow article will summarize the therapeutic properties of MSCs, quality attributes, expansion methods, as well as some major challenges these cells create when used in cell therapy applications. 

WinKQCL® tips and tricks

Software Beyond the Basics.

From LAL to rFC assay

Explore the history of LAL endotoxin testing towards the development of the recombinant Factor C assay. The American horseshoe crab population is now a vulnerable species, just one step from being endangered. The rFC assay has gone a long way to be accepted but as there is a growing recognition of its importance by various Pharmacopeia, a widespread adoption of the rFC method could be on the horizon.

Video on the division in CD34+ human cord blood HSCs

Live cell imaging performed with Nanolive’s 3D Cell Explorer for 15 hours (3 images/min) to capture CD34+ cell division.

CRISPR/Cas9 based genome engineering of NK cells using Nucleofector® Technology

How to handle the natural killers for genomic engineering purposes?

Learn from the authors about the potential overcome of some limitation of NK cell-based therapies and check for the detailed protocol of Cas9 RNP transfection. 

Maybe it is also a start for you? 

Tolerogenic dendritic cell-based therapy for multiple sclerosis

Can tolerogenic dendritic cells help to restore tolerance in autoimmune diseases?

Models for safety testing of biopharmaceuticals

A novel T cell: PMBC assay to test for immunogenicity.

Using HLA-typed cells in research

What’s the point about HLA status and why is it important in research?

Short guideline for an efficient transfection using Nucleofection® Technology of human dendritic cells

We propose an efficient way to achieve good transfection results in terms of viability and efficiency using Nucleofection® Technology.

3D model of colorectal tumouroids

The development of a reproducible 3D in vitro model of tumour growth.

Reprogramming of human erythroblasts into iPSC for Sickle Cell Disease research

The Nucleofection® Technology used for generation of three SCD-iPS and three control iPS cell lines.

Exciting new developments in the production of viral vaccines

This article highlights a few key hallmarks in vaccine development.

CAR-T therapy overview

CAR-T therapy is a new cutting edge treatment involving modification of human T cells, but also has some challenges to overcome. Learn more about it in a brief overview of this therapy.

Recombinant Factor C adopted into Ph. Eur.

During the last session of the European Pharmacopoeia Commission, endotoxin testing with rFC was adopted as general chapter 2.6.32. 

 

The importance of data integrity in the endotoxin test

Learn more about data integrity and how automation can help you there in endotoxin testing.

A big picture approach to recombinant protein production

This article summarizes the major elements of the protein production process.

Video protocol for CRISPR/Cas9 genome editing

Different techniques for genome editing in diverse cells and species.

Happy Holidays - Seasonal Greetings

Best wishes for 2020 - Your Scientific Support Team USA and Europe/Asia/Pacific.

New USP chapter <1085> guidelines on the endotoxins test

USP just released a new guidance chapter to provide supporting information on the endotoxins test.

Lonza’s Northern European endotoxin seminar held in Manchester, UK

As part of the European Endotoxin Seminar series Lonza recently held a 2 days workshop in Manchester.

In vitro exercise models used to study skeletal muscle responses

Electro-pulse stimulation is used in vitro to study the response of human-mouse hybrid myotubes.

Confidence for adopting the rFC method in your lab

Different aspects of the endotoxin testing are considered to shed some light on articles that question the use of rFC for release testing.

How 3D spheroids are reversing hyperglycemia

Islet-like structures generated in vitro from adult human liver stem cells revert hyperglycemia in diabetic SCID mice.

Endotoxin seminar for pharmaceutical industry held in Cologne, Germany

As part of the European Endotoxin Seminar series Lonza recently held a 2-days workshop in Cologne.

Spotlight on a cell type: Human hepatic stellates

Learn about human hepatic stellate cells, which are intrinsically involved in liver damage, and an article that may help study liver damage using cryopreserved human cells rather than animal liver models

Optimization of therapeutic gene editing in human hematopoietic stem cells

Re-activation of fetal hemoglobin expression by CRISPR-Cas9 for treatment of β-hemoglobino-pathies

Using longer single guides to increase editing efficiency

The authors describe a novel approach that leads to higher editing efficiency in CRISPR experiments

Endotoxin testing of blood-based samples

If you are a researcher or new to the LAL assay, testing serum or plasma samples for endotoxin may seem a daunting task. Our Technical Tips will help you.

 

The effect of light on media performance

Light exposure causes photoxidation which can generate harmful, highly reactive species that are damaging to your culture.

Scaling up for clinical use - CAR-T cell expansion

Improving the cultivation of CD19.CAR-T cells transfected with piggyBac system is a step towards clinical use.

Empowering NK cell immuno-therapy research using a novel genome editing protocol

Efficient CRISPR RNP genome editing of human Natural Killer cell using the 4D-Nucleofector® Device

Binding affinity of endotoxin to different types of plastic

Endotoxin recovery study with 4 different types of plastic sample containers.

Quick tips for successful Nucleofection® experiments

Sometimes it’s the basics that can make or break an experiment and Nucleofection® experiments are no different. Cell handling, proper culture conditions, and following the protocol are all critical. Here are some important things to keep in mind when performing your own Nucleofection® experiments.

Gut-brain microbiome potential influence on Alzheimers disease

Discovering the impact of GI-tract microbiome-generated neurotoxin on NF-L mRNA in the Alzheimers Brain

Tech tip: Screening consumables for Bacterial Endotoxin Testing (BET)

Lonza offers a guideline how to screen plastic accessories to be used with Bacterial Endotoxin Testing (BET)

Tech tips for primary cell culture: Common errors

Cell culture is expensive and time consuming. Effective technique and protocols can help keep cells healthy in culture. These are some common errors to avoid when culturing primary cells. 

The horseshoe crab experience

Helping the crabs while helping yourself.

PDA technical report on Low Endotoxin Recovery

Are you investigating Low Endotoxin Recovery (LER)? PDA has released its Technical Report 82 on this topic - learn what it's all about!

Understanding Alzheimer's disease variants

Scientists elucidating the mechanisms of the R47H Trem2 variant discover they cannot be replicated in humans

CRISPR-based genetic screen in physiological relevant primary cells

Review of "CRISPR-based Genetic Screen in Physiological Relevant Primary Cells" from Judd Hultquist.

Interested in our webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Knowledge Center

Need technical data?

Browse our Cell and Transfection, Citation, FAQ and Culture Media Technical Databases.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Important note: The user bears the sole responsibility for determining the existence of any third party rights, as well as obtaining any necessary licenses.